Cargando…
Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative therapy for patients suffering from hematological malignancies via the donor immune system driven graft-versus-leukemia effect. However, the therapy is mainly limited by severe acute and chronic graft-versus-host...
Autores principales: | Braun, Lukas M., Zeiser, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635802/ https://www.ncbi.nlm.nih.gov/pubmed/34868001 http://dx.doi.org/10.3389/fimmu.2021.760199 |
Ejemplares similares
-
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease
por: Apostolova, Petya, et al.
Publicado: (2016) -
Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
por: Braun, Lukas M., et al.
Publicado: (2021) -
Editorial: Non-coding RNAs and Graft versus Host Disease
por: Reddy, Pavan, et al.
Publicado: (2018) -
The Role of MicroRNAs in Myeloid Cells during Graft-versus-Host Disease
por: Chen, Sophia, et al.
Publicado: (2018) -
Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System
por: Vinnakota, Janaki Manoja, et al.
Publicado: (2021)